Next Article in Journal
Screening of Hanseniaspora Strains for the Production of Enzymes with Potential Interest for Winemaking
Next Article in Special Issue
Characterizing the Phenotypic Responses of Escherichia coli to Multiple 4-Carbon Alcohols with Raman Spectroscopy
Previous Article in Journal
Development of Novel Textile Bioreactor for Anaerobic Utilization of Flocculating Yeast for Ethanol Production
Previous Article in Special Issue
Activity of Lactobacillus brevis Alcohol Dehydrogenase on Primary and Secondary Alcohol Biofuel Precursors
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Fermentation
Volume 1
Issue 1
10.3390/fermentation1010113
fermentation-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antisense-RNA-Mediated Gene Downregulation in Clostridium pasteurianum

by
Michael E. Pyne
1,†,
Murray Moo-Young
1,
Duane A. Chung
1,2,* and
C. Perry Chou
1,*
1
Department of Chemical Engineering, University of Waterloo, Waterloo, ON N2L 3G1, Canada
2
Algaeneers Inc., Hamilton, ON L8N 3Z5, Canada
*
Authors to whom correspondence should be addressed.
†
Present address: Department of Biology and Centre for Structural and Functional Genomics, Concordia University, Montréal, QC H4B 1R6, Canada
Fermentation 2015, 1(1), 113-126; https://doi.org/10.3390/fermentation1010113
Submission received: 22 September 2015 / Revised: 6 November 2015 / Accepted: 2 December 2015 / Published: 9 December 2015
(This article belongs to the Special Issue Metabolic Engineering)
Browse Figures
Versions Notes

Abstract

:
Clostridium pasteurianum is receiving growing attention for its unique metabolic properties, particularly its ability to convert waste glycerol and glycerol-rich byproducts into butanol, a prospective biofuel. Genetic tool development and whole genome sequencing have recently been investigated to advance the genetic tractability of this potential industrial host. Nevertheless, methodologies for tuning gene expression through plasmid-borne expression and chromosomal gene downregulation are still absent. Here we demonstrate plasmid-borne heterologous gene expression and gene knockdown using antisense RNA in C. pasteurianum. We first employed a common thermophilic β-galactosidase (lacZ) gene reporter system from Thermoanaerobacterium thermosulfurogenes to characterize two promoters involved in the central fermentative metabolism of C. pasteurianum. Due to a higher level of constitutive lacZ expression compared to the ferredoxin gene (fdx) promoter, the thiolase (thl) promoter was selected to drive expression of asRNA. Expression of a lacZ asRNA resulted in 52%–58% downregulation of β-galactosidase activity compared to the control strain throughout the duration of culture growth. Subsequent implementation of our asRNA approach for downregulation of the native hydrogenase I gene (hydA) in C. pasteurianum resulted in altered end product distribution, characterized by an increase in production of reduced metabolites, particularly butyrate (40% increase) and ethanol (25% increase). Knockdown of hydA was also accompanied by increased acetate formation and lower levels of 1,3-propanediol, signifying a dramatic shift in cellular metabolism in response to inhibition of the hydrogenase enzyme. The methodologies described herein for plasmid-based heterologous gene expression and antisense-RNA-mediated gene knockdown should promote rational metabolic engineering of C. pasteurianum for enhanced production of butanol as a prospective biofuel.

Graphical Abstract

1. Introduction

Clostridium pasteurianum is a strictly anaerobic, Gram-positive, spore-forming bacterium that has received growing biotechnological attention for its capacity to ferment low-value waste feedstocks, particularly crude glycerol, to commodity chemicals and biofuels [1,2,3]. C. pasteurianum is the only known organism capable of converting glycerol to butanol [4], an attractive biofuel that is superior to ethanol [5,6,7]. Cheap crude glycerol is currently available in abundance as a result of the tremendous growth experienced by global biodiesel and bioethanol industries in recent years [8,9]. Biodiesel production yields 10% (w/w) crude glycerol, while up to 20 liters of glycerol-rich thin stillage can result from the production of only 1 liter of bioethanol [10]. In 2007, global biodiesel production capacity from a total of 119 countries was estimated at 51 billion liters [11], leading to a plummet in the price of crude glycerol to approximately $0.05/lb [8]. Consequently, C. pasteurianum has become an attractive prospective industrial host for the production of butanol from abundant and renewable waste glycerol [3]. Up to now, few genetic tools have been developed for metabolic engineering of this important bacterium. We recently developed a high-efficiency electrotransformation procedure for gene transfer to C. pasteurianum [12], in addition to an intron-based method of chromosomal gene disruption [13]. Several genome sequencing projects are underway [14,15,16], including two completed genome sequences [17,18] and one genomic analysis report [19]. Collectively these developments serve as the initial steps toward extensive metabolic engineering of this unique species [20].
A fundamental facet of metabolic engineering is the ability to decrease the expression of genes involved in competing metabolic pathways through the use of gene knockdown and knockout techniques [21]. Gene knockouts cause complete inhibition of gene expression and, therefore, often lead to lethal phenotypes, particularly for genes involved in central metabolic pathways [22]. For example, disruption of the hydrogenase or thiolase genes [23] in C. acetobutylicum is presumed to result in cell death, thus placing significant constraints on rational metabolic engineering strategies employing gene knockout. Antisense-RNA-mediated gene downregulation, on the other hand, is a more refined approach for limiting expression of native genes and metabolic pathways, as production of the target protein is still permitted, though at a substantially decreased level [24,25]. For organisms that carry out highly branched and complex fermentations, such as C. pasteurianum [5,26], metabolic engineering is a very useful tool for limiting or entirely abolishing carbon and electron fluxes through competing pathways [20]. Although C. pasteurianum naturally produces appreciable quantities of butanol (up to 17 g·L−1 [27]) from glycerol, 1,3-propanediol also accumulates in the culture medium, thus limiting flux through the butanol biosynthetic pathway. Gene downregulation is expected to be of great value to metabolic engineering of C. pasteurianum [3], as current understanding of glycerol catabolism in Clostridium dictates that disruption of the reductive 1,3-propanediol pathway will uncouple biomass formation and glycerol dissimilation [4], leading to inability to metabolize glycerol and subsequent cell death. Therefore, attenuation of competing pathways via antisense-RNA-mediated gene knockdown is a viable option for increasing butanol titer from fermentation of glycerol by C. pasteurianum.
Antisense RNAs are designed to possess partial or complete complementarity to a target mRNA, leading to base-pairing and degradation of the resulting RNA duplex prior to mRNA translation [24,28,29]. Alternatively, it has been proposed that mRNA–asRNA complexes sterically block translational machinery, resulting in reduced levels of the target protein [24]. This strategy has been employed in several clostridial species, including C. acetobutylicum [24,25,30], C. cellulolyticum [31], and C. saccharoperbutylacetonicum [32], for downregulation of competing metabolic pathways, including butyrate and acetone formation pathways, to enhance butanol titers, selectivity, and tolerance [24,25,30,31,33,34]. Degree of gene downregulation has been shown to vary, for example between 44% and 92% in one report [25], and is commonly quantified by measuring enzyme activity or production of protein target via Western blot analysis. Downregulation can also be finely tuned by selection of the promoter driving transcription of the asRNA, where stronger promoters presumably generate more asRNA product, leading to a greater degree of downregulation [24]. Promoters utilized in successful asRNA approaches include ones from genes involved in central carbon metabolism, such as phosphotransbutyrylase (ptb) and thiolase (thl) [35], as well as butanol dehydrogenase (bdh) [32].
In this report, we engineered C. pasteurianum through manipulation of gene expression. We employed a common clostridial gene reporter system based on the Thermoanaerobacterium thermosulfurogenes β-galactosidase gene (lacZ) [35] to assess the relative strength of two gene promoters involved in the central fermentative metabolism of C. pasteurianum. We then selected the native C. pasteurianum thiolase promoter to drive transcription of asRNA targeted to our lacZ reporter gene. To assess the efficacy of gene knockdown in C. pasteurianum, we targeted the primary hydrogenase gene (hydA) for downregulation using our devised asRNA approach. Collectively, we demonstrate that asRNA gene knockdown and plasmid-based heterologous gene expression, along with a complete genome sequence [18,19] and previously developed genetic tools [12,13], should promote the feasibility of metabolic engineering and strain optimization of C. pasteurianum.

2. Experimental Section

2.1. Bacterial Strains, Cultivation Conditions, and Electrotransformation

Bacterial strains utilized in this work are listed in Table 1. C. pasteurianum ATCC 6013 was cultivated in 2×YTG medium (per liter: 16 g tryptone, 10 g yeast extract, 5 g glucose, 4 g sodium chloride, pH 6.2) and spores were maintained on solidified 2×YTG medium containing 12 g·L−1 agar, as described previously [12]. Vegetative cultures were prepared by suspending and heat shocking a sporulated colony at 80 °C for 10 min. Recombinant C. pasteurianum strains were selected using 10 μg·mL−1 thiamphenicol or 6 μg·mL−1 clarithromycin. Electrotransformation of C. pasteurianum was performed according to a previous report [12].
Table
Table 1. Strains, plasmids, and oligonucleotides employed in this study.
Table 1. Strains, plasmids, and oligonucleotides employed in this study.
Strains or PlasmidsRelevant CharacteristicsSource or Reference
Strains
Escherichia coli DH5αF− endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG φ80dlacZ∆M15 ∆(lacZYA-argF)U169, hsdR17(rK−mK+), λ−Lab stock
Escherichia coli ER1821F− endA1 glnV44 thi-1 relA1? e14−(mcrA−) rfbD1? spoT1? ∆(mcrC-mrr)114::IS10Lab stock; New England Biolabs
Clostridium pasteurianum ATCC 6013Wild-typeAmerican type culture collection
Plasmids
pFnuDIIMKnE. coli vector expressing the M.FnuDII methyltransferase for plasmid methylation prior to electrotransformation of C. pasteurianum (KnR; p15A ori)[12]
pHT3Promoterless E. coli-C. pasteurianum β-galactosidase gene expression reporter vector (ApR; ColE1 ori; EmR; pIM13 ori)[35]
pMTL85141E. coli-C. pasteurianum shuttle vector (ColE1 ori; TmR; pIM13 ori)[36]
pSY6catPE. coli-Clostridium group II intron expression vector (ApR; ColE1 ori; TmR; pIM13 ori)[12]
pHT3catPThiamphenicol-resistant derivative of pHT3This study; [37]
pHT3catP-fdxDerived by transcriptionally fusing the C. pasteurianum fdx promoter with the lacZ gene of pHT3catPThis study
pHT3catP-thlDerived by transcriptionally fusing the C. pasteurianum thl promoter with the lacZ gene of pHT3catPThis study
pHTaslacZ110Vector expressing a 110 nt lacZ asRNA from the C. pasteurianum thl promoterThis study
pHTashydAVector expressing a 175 nt hydA asRNA from the C. pasteurianum thl promoterThis study
OligonucleotideSequence (5ʹ–3ʹ) *
Pfdx.NarI.SCAGAACGGCGCCGAAGATATAAGAAAAAGACTCCCAAAGG
Pfdx.XmaI.ASATCATACCCGGGCCATAACTTATTGTATCATGTTTTTAAAC
Pthl.NarI.SCTGTAGGCGCCGATATAGTCTATAAGCATTTAGATGGAGTTAG
Pthl.XmaI.ASAAATACCCGGGTCGATTGTTATTTAATTCACAATTTAATTATAACC
* Relevant restriction endonuclease recognition sequences are underlined.

2.2. DNA Isolation, Manipulation, and Plasmid Construction

Plasmids and oligonucleotides utilized in this work are shown in Table 1. Oligonucleotides were synthesized by Integrated DNA Technologies (IDT; Coralville, IA, USA) at the 25 nanomole scale using standard desalting. Restriction endonucleases, Quick Ligation Kit, Standard Taq DNA Polymerase, and Phusion DNA Polymerase were purchased from New England Biolabs (Ipswich, MA, USA). Molecular biology kits for purification of plasmid DNA, PCR products, and gel purified DNA and custom gene synthesis were purchased from Bio Basic Inc. (Markham, ON, USA). Recombinant DNA methods were performed according to standard procedures [38]. Total genomic DNA was isolated from C. pasteurianum as previously described [13].
A thiamphenicol derivative of pHT3 [35], named pHT3catP [37], was constructed by subcloning a 1314 bp ClaI + SacI restriction fragment of pSY6catP [12] containing a thiamphenicol-resistance cassette into the corresponding restriction sites of the erythromycin-resistance determinant of pHT3. Transcriptional promoter fusions with lacZ in pHT3catP were prepared by amplifying putative fdx and thl promoter regions from C. pasteurianum total genomic DNA using primer pairs Pfdx.NarI.S + Pfdx.XmaI.AS and Pthl.NarI.S + Pthl.XmaI.AS, respectively. The resulting 565 bp (fdx) and 511 bp (thl) PCR products were digested with NarI + XmaI and ligated into the corresponding sites of pHT3catP to generate pHT3catP-fdx and pHT3catP-thl, respectively. To construct plasmid pHTaslacZ110, a lacZ asRNA expression cassette containing the C. pasteurianum thl promoter, lacZ asRNA, and C. pasteurianum fdx transcriptional terminator was obtained as a custom AhdI- and BstAPI-flanked gene synthesis fragment. The resulting 517 bp fragment was digested with AhdI + BstAPI and inserted into the corresponding restriction sites of pHT3catP-thl. Plasmid pHTashydA was constructed by obtaining a 276 bp BamHI- and BstXI-flanked custom gene synthesis product possessing a 175 nt hydA asRNA upstream of the C. pasteurianum fdx transcriptional terminator. Antisense RNA was designed to target the RBS and 164 nt of the 5’ hydA coding region. The resulting synthetic product was digested with BamHI + BstXI and ligated into the corresponding sites of pHT3catP-thl for transcriptional fusion of the hydA asRNA with the C. pasteurianum thl promoter.

2.3. Strain Cultivation

β-Galactosidase expression and enzymatic assay were performed as previously described [35,39], with slight modifications. For expression of recombinant C. pasteurianum ATCC 6013 harboring pHT3catP, pHT3catP-fdx, pHT3catP-thl, or pHTaslacZ110, 45 mL samples were removed from each flask in duplicate every 3–5 h starting at an A600 of ~0.5. Cells were harvested from cultures by centrifugation at 10,000× g for 10 min at 4 °C, and the resulting cell pellets were stored at −80 °C. Cell pellets were thawed on ice, resuspended in Z buffer to an OD600 of 20 in a minimum volume of 1 mL, and lysed by incubation in the presence of 1 mg/mL lysozyme for 1 h at 37 °C, unless specified otherwise. One mL of the resulting lysates was cleared of cell debris by centrifugation at 16,000× g for 15 min at 4 °C and the supernatant was heated in a 60 °C water bath for 30 min. Denatured heat-labile proteins were cleared by centrifugation at 16,000× g for 30 min at 4 °C. Supernatants were stored at 4 °C prior to enzymatic assays.
Shake flask cultures expressing hydA asRNA (pHTashydA) or the control plasmid (pMTL85141) were cultivated in 50 mL of semi-defined medium [4,40] containing per liter: 0.5 g KH2PO4, 0.5 g K2HPO4, 7.35 g (NH4)2SO4, 3.0 g CaCO3, 5.08 g Bacto yeast extract, 0.2 g MgSO4·7H2O, 0.02 g CaCl2·2H2O, 0.06 g FeSO4·7H2O, 1 mg resazurin, and 2 mL trace element solution SL 7. The initial pH of the medium was adjusted to 6.0 prior to sterilization. Glycerol was sterilized separately as a stock solution and added to culture flasks to attain a final concentration of 50 g L−1. Cysteine–HCl (0.5 g L−1) was used to reduce growth medium. Cultures were incubated anaerobically with slight agitation (150 rpm) for 40–50 h. Seed cultures were prepared in 2×YTG medium from sporulated heat-shocked colonies.

2.4. Analytical Methods

Cell growth was quantified spectrophotometrically by measuring culture optical density at 600 nm (OD600). β-Galactosidase activity was assayed as described [35] at 60 °C by measuring optical density at 420 nm (OD420) following development of yellow color resulting from cleavage of ortho-nitrophenyl-β-galactoside (ONPG) to orthonitrophenol. Specific β-galactosidase activity is expressed in Miller units [39].
Shake flask culture supernatants were analyzed for metabolite production by LC-10AT HPLC analysis (Shimadzu, Kyoto, Japan) containing a RID-10A refractive index detector (Shimadzu, Kyoto, Japan) and Aminex HPX-87H column (Bio-Rad Laboratories, Richmond, CA, USA). The mobile phase consisted of 0.005 M H2SO4 (pH 2.0) at a flow rate of 0.6 mL·min−1. Data processing was performed using Clarity Lite (DataApex, Prague, Czech Republic). Metabolite titers reported represent the average of two biological replicates.

3. Results

A modified thiamphenicol-selectable reporter system, pHT3catP, containing a thermophilic β-galactosidase gene, lacZ [35], was utilized to assess the function of two promoters involved in the central metabolism of C. pasteurianum. Putative promoter regions from the native ferredoxin (fdx) [41] and thiolase (thl) [42] genes of C. pasteurianum were cloned upstream of lacZ in pHT3catP to generate transcriptional fusions (Pfdx-lacZ and Pthl-lacZ, respectively). The respective plasmids, pHT3catP-fdx and pHT3catP-thl, in addition to the promoterless pHT3catP control vector, were electrotransformed to C. pasteurianum ATCC 6013 and the resulting recombinant strains were used to assess expression of lacZ (Figure 1). The control plasmid pHT3catP failed to generate β-galactosidase activity (<8 MU) throughout the duration of cell growth. Conversely, both pHT3catP-fdx and pHT3catP-thl yielded significant β-galactosidase activity. Specifically, the Pfdx-lacZ construct generated a lower maximal β-galactosidase activity (144 MU; Figure 1A), compared to the Pthl-lacZ strain (439 MU; Figure 1B). Although the fdx promoter has been widely used for gene expression in a range of clostridia [43,44], we opted for the stronger thl promoter for subsequent expression of asRNA in C. pasteurianum.
Fermentation 01 00113 g001 1024
Figure 1. Time course β-galactosidase activities of static flask cultures harboring lacZ transcriptional fusion constructs. (A) Pfdx-lacZ cassette (pHT3catP-fdx); (B) Pthl-lacZ cassette (pHT3catP-thl).
Figure 1. Time course β-galactosidase activities of static flask cultures harboring lacZ transcriptional fusion constructs. (A) Pfdx-lacZ cassette (pHT3catP-fdx); (B) Pthl-lacZ cassette (pHT3catP-thl).
Fermentation 01 00113 g001
To assess the efficacy of asRNA-mediated gene downregulation in C. pasteurianum, we again utilized thermophilic lacZ as a reporter gene. An asRNA cassette was designed by placing a 110 nt lacZ asRNA under transcriptional control of the thl promoter (Pthl-aslacZ110) and a transcriptional terminator derived from the C. pasteurianum fdx gene immediately downstream of the asRNA sequence. The 110 nt lacZ asRNA was designed to target 66 bp upstream of the initiation codon, including the ribosome binding site, and the first 44 bp of the lacZ coding sequence. The resulting Pthl-aslacZ110 cassette was inserted into plasmid pHT3catP-thl, generating pHTaslacZ110. In this configuration, the lacZ asRNA cassette was expressed from a plasmid backbone also containing the full-length Pthl-lacZ gene, resulting in a plasmid harboring two copies of the same thl promoter (Figure 2A). Following electrotransformation, recombinant C. pasteurianum strains respectively harboring pHT3catP, pHT3catP-thl, or pHTaslacZ110 were cultivated in parallel and cells were harvested and assayed for β-galactosidase activity at various culture time points (Figure 2B). The Pthl-aslacZ110 asRNA strain produced only 52%–58% of the β-galactosidase activity generated by the Pthl-lacZ control strain, thus demonstrating appreciable downregulation of plasmid-encoded lacZ.
Fermentation 01 00113 g002 1024
Figure 2. Antisense-RNA-mediated gene downregulation in C. pasteurianum. (A) Antisense RNA strategy and proposed mechanism of gene downregulation based on β-galactosidase enzymatic assay. dsRNase refers to putative host RNase(s) recognizing double-stranded RNA molecules; (B) β-Galactosidase activities of static flask cultures harboring promoterless lacZ plasmid pHT3catP, Pthl-lacZ plasmid pHT3catP-thl, and Pthl-aslacZ110 antisense RNA plasmid pHTaslacZ110.
Figure 2. Antisense-RNA-mediated gene downregulation in C. pasteurianum. (A) Antisense RNA strategy and proposed mechanism of gene downregulation based on β-galactosidase enzymatic assay. dsRNase refers to putative host RNase(s) recognizing double-stranded RNA molecules; (B) β-Galactosidase activities of static flask cultures harboring promoterless lacZ plasmid pHT3catP, Pthl-lacZ plasmid pHT3catP-thl, and Pthl-aslacZ110 antisense RNA plasmid pHTaslacZ110.
Fermentation 01 00113 g002
Based on successful downregulation of heterologous lacZ using asRNA, we aimed to extend our approach to a native C. pasteurianum gene involved in the organism’s central fermentative metabolism. Accordingly, we designed a 175 nt asRNA cassette targeted to the C. pasteurianum hydrogenase I gene (hydA). The resulting plasmid (pHTashydA175), in addition to the control plasmid lacking asRNA (pMTL85141), were transferred to C. pasteurianum and shake flask cultivations were performed using a semi-defined growth medium containing 50 g L−1 glycerol. Compared to the control strain, the hydA asRNA strain produced markedly less gas, as evidenced from a reduced amount of bubbles and foam at the surface of shake flasks. This outcome is consistent with decreased hydrogen gas evolution resulting from hydrogenase inhibition. Cultures harboring pHTashydA175 also reached a higher final cell density and exhibited a shorter cultivation time (Table 2). End product analysis of cultures harboring pMTL85141 control plasmid and pHTashydA asRNA plasmid revealed dramatic differences in product distribution. The hydA asRNA strain produced enhanced levels of acetate (137% increase), butyrate (40% increase), ethanol (25% increase) and, to a lesser extent, butanol (12% increase) (Table 2). 1,3-Propanediol was the only metabolite that was produced at a lower level (43% decrease) following expression of asRNA relative to the control strain. Overall, hydA asRNA expression increased total acid production by 108%, while total alcohol formation was largely unaffected.
Table
Table 2. End product analysis of shake flask cultures harboring pMTL85141 and pHTashydA.
Table 2. End product analysis of shake flask cultures harboring pMTL85141 and pHTashydA.
StrainCulture time (h)OD600Substrate and product titers (g L-1)
GlycerolAcetateButyrateEthanolButanol1,3-PDOTotal acidsTotal alcohols
WT (pMTL85141)52.57.6 ± 0.411.4 ± 0.060.38 ± 0.00.15 ± 0.021.6 ± 0.048.9 ± 0.33.3 ± 0.30.53 ± 0.0213.8 ± 0.05
WT (pHTashydA)43.010.3 ± 0.0712.3 ± 0.10.90 ± 0.40.21 ± 0.02.0 ± 0.110.0 ± 0.02.3 ± 0.031.1 ± 0.414.4 ± 0.07

4. Discussion

Fundamental genetic techniques to modulate host gene expression through either gene upregulation (i.e., overexpression) or downregulation (i.e., knockdown) have found widespread use within the clostridia for various strain construction applications [21]. Since a method of gene transfer has only recently been reported for C. pasteurianum [12], techniques to manipulate gene expression are lacking for this species. Here we demonstrate the utility of both plasmid-based heterologous gene expression and asRNA-mediated gene knockdown in C. pasteurianum.
By generating transcriptional fusions, gene reporter systems facilitate characterization of a range of host promoters, resulting in a diverse promoter library, ideally exhibiting a broad spectrum of expression strengths. Most frequently, strong constitutive promoters are desired to maximize expression of a target gene or metabolic pathway throughout the duration of culture growth [20]. To compare promoters and provide a quantitative means of assessing relative promoter strength in C. pasteurianum, we selected a thermophilic β-galactosidase gene reporter system [35], since it has found widespread use in the clostridia [20]. We selected promoters from the C. pasteurianum thl and fdx genes, since the C. acetobutylicum thl gene promoter leads to high level constitutive gene expression [35] and the ferredoxin protein accounts for up to 2% of total soluble protein in growing cultures of C. pasteurianum [45]. We showed that the C. pasteurianum thl promoter generated roughly three-fold higher maximal β-galactosidase activity compared to the native fdx promoter (Figure 1). A similar result was obtained using C. acetobutylicum, as the native thl promoter out-performed promoters from the C. acetobutylicum phosphotransbutyrylase (ptb) and acetoacetate decarboxylase (adc) genes [35]. Thiolase, which catalyzes the transition from C2 to C4 intermediates in clostridial metabolism [5,26], would be expected to be expressed at a high level in both of these organisms, since the preferred products of glucose fermentation are butyrate (C4) in the case of C. pasteurianum [46] and butyrate and butanol (C4) in the case of C. acetobutylicum [5]. Although the thl promoter proved superior in C. pasteurianum, the C. pasteurianum fdx promoter still produced appreciable β-galactosidase activity owing to ferredoxin’s central role in clostridial fermentative metabolism. Further, the C. pasteurianum fdx promoter has been shown to function in C. acetobutylicum and C. sporogenes [44], in addition to C. cellulolyticum [43,47] and E. coli [41].
In addition to promoter characterization, expression of lacZ in this study exemplifies the first demonstration of quantifiable heterologous gene expression in C. pasteurianum. Accordingly, the thl and fdx promoters, along with the associated pHT3 vector backbone, which is based on pIMP1 [48] and contains the commonly employed pIM13 Gram-positive replication module, together constitute the fundamental genetic components necessary for expressing heterologous genes and pathways in C. pasteurianum. In this context, the thl promoter is favored for applications demanding high-level gene expression, while the fdx promoter could be better suited in instances where maximal levels of gene expression are not paramount or desirable. Further, although not investigated in this report, the vector elements required for heterologous gene expression can also be utilized to enhance expression of native C. pasteurianum chromosomal genes through plasmid-based gene overexpression. Both heterologous and homologous gene expression strategies are vital to producing superior host strains through metabolic engineering and strain optimization [20].
Based on time course studies of β-galactosidase activity (Figure 1), we selected the thl promoter to drive transcription of asRNA in C. pasteurianum (Figure 2A). Using this approach, we achieved greater than 50% knockdown of lacZ at multiple time points throughout culture growth (Figure 2B), demonstrating that asRNA gene downregulation represents a viable option for controlling gene expression in C. pasteurianum. Since asRNA size and secondary structure are important design considerations [25] that were not investigated in this study, we advise the use of transcriptional terminators to avoid generation of superfluous non-homologous sequence at the 3ʹ end of asRNAs that may interfere with hybridization to target mRNAs. We also recommend testing multiple asRNAs in parallel for each knockdown target, as predicting asRNA effectiveness could prove challenging without assaying multiple designs.
The efficacy of our asRNA gene knockdown methodology was verified by targeting the primary hydrogenase gene (hydA) in C. pasteurianum. We observed a dramatic shift in end product distribution characterized by increased production of acids (acetate and butyrate) and ethanol (Table 2). Based on current models of clostridial metabolism, inhibition of the hydrogenase enzyme is expected to result in a buildup of reduced ferredoxin, which is subsequently utilized to drive reduction of NAD+ to NADH by the ferredoxin:NAD+ oxidoreductase enzyme. The NADH formed in this reaction is then employed for generation of reduced end products, such as ethanol and butanol. This shift in carbon and electron flow has been widely documented using carbon monoxide gassing in C. acetobutylicum [49] and C. pasteurianum [27], which also results in inhibition of the hydrogenase system. While we observed higher levels of butyrate and ethanol, both NADH-consuming pathways, the butanol pathway was only slightly stimulated, suggesting that excess NADH formed from the ferredoxin:NAD+ oxidoreductase enzyme was not utilized for production of butanol. Strikingly, acetate formation, which is not a redox pathway, was dramatically increased upon expression of hydA asRNA, exemplifying an unexpected shift in acid production. In total, combined acid production (acetate and butyrate) more than double in the hydA asRNA strain, suggesting that hydrogenase knockdown affects cellular energetics, as acetate and butyrate pathways result in ATP formation via substrate level phosphorylation. Indeed, the hydA knockdown strain exhibited a shorter cultivation time and increased biomass production (Table 2), which are consistent with a higher ATP yield. Finally, expression of hydA asRNA also exhibited an unexpected decline in 1,3-propanediol production, which ostensibly contrasts the presumed flow of electrons outlined above. Overall, however, we have observed substantial variability in 1,3-propanediol titer across fermentations conducted under seemingly identical conditions (data not shown), as 1,3-propanediol appears to be the most variable metabolite produced by C. pasteurianum. A similar lack of pathway control has been noted by others [3,4]. Therefore, the decreased production of 1,3-propanediol observed in this study may not represent a direct consequence of hydrogenase downregulation. Collectively, the findings unveiled in this study through downregulation of hydA underpin the complex and highly branched fermentative metabolism exhibited by C. pasteurianum and provide a groundwork for rational metabolic engineering of this important industrial bacterium.

5. Conclusions

In this work, we show that plasmid-based heterologous gene overexpression and asRNA-mediated gene downregulation are effective tools for altering gene expression in C. pasteurianum. The constitutive fdx and thl transcriptional promoters characterized in this study should find use in future C. pasteurianum gene expression applications, including plasmid-based expression of non-native pathways and cellular activities, as well as overexpression of key C. pasteurianum genes. We also show that central fermentative metabolism in C. pasteurianum can be dramatically altered through expression of asRNA targeted to the primary hydrogenase mRNA. Our devised asRNA methodology should expand the available set of genetic tools towards metabolic engineering of C. pasteurianum, through systematic knockdown of undesirable and unproductive chromosomal genes and metabolic pathways.

Acknowledgments

This work was supported in part by the Natural Sciences and Engineering Research Council (NSERC) and the Canada Research Chair (CRC) program of Canada.

Author Contributions

Michael E. Pyne helped conceived of the study, participated in its design and coordination, carried out the experiments, and drafted the manuscript. Murray Moo-Young participated in the study design and coordination. Duane A. Chung and C. Perry Chou helped conceive of the study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.

Conflicts of Interest

Duane A. Chung is a founder and employee of Algaeneers Inc., at which Michael E. Pyne has also been employed. Algaeneers Inc. has a financial interest in production of biofuels using microorganisms.

References

  1. Ahn, J.H.; Sang, B.I.; Urn, Y. Butanol production from thin stillage using Clostridium pasteurianum. Bioresour. Technol. 2011, 102, 4934–4937. [Google Scholar] [CrossRef] [PubMed]
  2. Ensen, T.O.; Kvist, T.; Mikkelsen, M.J.; Christensen, P.V.; Westermann, P. Fermentation of crude glycerol from biodiesel production by Clostridium pasteurianum. J. Ind. Microbiol. Biotechnol. 2012, 39, 709–717. [Google Scholar]
  3. Taconi, K.A.; Venkataramanan, K.P.; Johnson, D.T. Growth and solvent production by Clostridium pasteurianum ATCC (R) 6013 (Tm) utilizing biodiesel-derived crude glycerol as the sole carbon source. Environ. Prog. Sustain. Energy 2009, 28, 100–110. [Google Scholar] [CrossRef]
  4. Biebl, H. Fermentation of glycerol by Clostridium pasteurianum—Batch and continuous culture studies. J. Ind. Microbiol. Biotechnol. 2001, 27, 18–26. [Google Scholar] [CrossRef] [PubMed]
  5. Lee, S.Y.; Park, J.H.; Jang, S.H.; Nielsen, L.K.; Kim, J.; Jung, K.S. Fermentative butanol production by Clostridia. Biotechnol. Bioeng. 2008, 101, 209–228. [Google Scholar] [CrossRef] [PubMed]
  6. Pfromm, P.H.; Amanor-Boadu, V.; Nelson, R.; Vadlani, P.; Madl, R. Bio-butanol vs. bio-ethanol: A technical and economic assessment for corn and switchgrass fermented by yeast or Clostridium acetobutylicum. Biomass Bioenergy 2010, 34, 515–524. [Google Scholar] [CrossRef]
  7. Swana, J.; Yang, Y.; Behnam, M.; Thompson, R. An analysis of net energy production and feedstock availability for biobutanol and bioethanol. Bioresour. Technol. 2011, 102, 2112–2117. [Google Scholar] [CrossRef] [PubMed]
  8. Johnson, D.T.; Taconi, K.A. The glycerin glut: Options for the value-added conversion of crude glycerol resulting from biodiesel production. Environ. Prog. 2007, 26, 338–348. [Google Scholar] [CrossRef]
  9. Yazdani, S.S.; Gonzalez, R. Anaerobic fermentation of glycerol: A path to economic viability for the biofuels industry. Curr. Opin. Biotechnol. 2007, 18, 213–219. [Google Scholar] [CrossRef] [PubMed]
  10. Van Haandel, A.C.; Catunda, P.F.C. Profitability increase of alcohol distilleries by the rational use of byproducts. Water Sci. Technol. 1994, 29, 117–124. [Google Scholar]
  11. Johnston, M.; Holloway, T. A global comparison of national biodiesel production potentials. Environ. Sci. Technol. 2007, 41, 7967–7973. [Google Scholar] [CrossRef] [PubMed]
  12. Pyne, M.E.; Moo-Young, M.; Chung, D.A.; Chou, C.P. Development of an electrotransformation protocol for genetic manipulation of Clostridium pasteurianum. Biotechnol. Biofuels 2013, 6, 50. [Google Scholar] [CrossRef] [PubMed]
  13. Pyne, M.E.; Moo-Young, M.; Chung, D.A.; Chou, C.P. Expansion of the genetic toolkit for metabolic engineering of Clostridium pasteurianum: Chromosomal gene disruption of the endogenous cpaai restriction enzyme. Biotechnol. Biofuels 2014, 7, 163. [Google Scholar] [CrossRef] [PubMed]
  14. Kolek, J.; Sedlář, K.; Provazník, I.; Patáková, P. Draft genome sequence of Clostridium pasteurianum NRRL B-598, a potential butanol or hydrogen producer. Genome Announc. 2014, 2. [Google Scholar] [CrossRef] [PubMed]
  15. Pyne, M.E.; Utturkar, S.; Brown, S.D.; Moo-Young, M.; Chung, D.A.; Chou, C.P. Improved draft genome sequence of Clostridium pasteurianum strain ATCC 6013 (DSM 525) using a hybrid next-generation sequencing approach. Genome Announc. 2014, 2, e00790-14. [Google Scholar] [CrossRef] [PubMed]
  16. Rappert, S.; Song, L.; Sabra, W.; Wang, W.; Zeng, A.P. Draft genome sequence of type strain Clostridium pasteurianum DSM 525 (ATCC 6013), a promising producer of chemicals and fuels. Genome Announc. 2013, 1. [Google Scholar] [CrossRef] [PubMed]
  17. Poehlein, A.; Grosse-Honebrink, A.; Zhang, Y.; Minton, N.P.; Daniel, R. Complete genome sequence of the nitrogen-fixing and solvent-producing Clostridium pasteurianum DSM 525. Genome Announc. 2015, 3. [Google Scholar] [CrossRef] [PubMed]
  18. Rotta, C.; Poehlein, A.; Schwarz, K.; Mcclure, P.; Daniel, R.; Minton, N.P. Closed genome sequence of Clostridium pasteurianum ATCC 6013. Genome Announc. 2015, 3. [Google Scholar] [CrossRef] [PubMed]
  19. Pyne, M.E.; Liu, X.; Moo-Young, M.; Chung, D.A.; Chou, C.P. Genomic-directed analysis of prophage excision, host defence systems, and central fermentative metabolism in Clostridium pasteurianum. unpublished work. 2015. [Google Scholar]
  20. Pyne, M.E.; Bruder, M.; Moo-Young, M.; Chung, D.A.; Chou, C.P. Technical guide for genetic advancement of underdeveloped and intractable Clostridium. Biotechnol. Adv. 2014, 32, 623–641. [Google Scholar] [CrossRef] [PubMed]
  21. Papoutsakis, E.T. Engineering solventogenic Clostridia. Curr. Opin. Biotechnol. 2008, 19, 420–429. [Google Scholar] [CrossRef] [PubMed]
  22. Song, C.W.; Lee, J.; Lee, S.Y. Genome engineering and gene expression control for bacterial strain development. Biotechnol. J. 2015, 10, 56–68. [Google Scholar] [CrossRef] [PubMed]
  23. Cooksley, C.M.; Zhang, Y.; Wang, H.Z.; Redl, S.; Winzer, K.; Minton, N.P. Targeted mutagenesis of the Clostridium acetobutylicum acetone-butanol-ethanol fermentation pathway. Metab. Eng. 2012, 14, 630–641. [Google Scholar] [CrossRef] [PubMed]
  24. Desai, R.P.; Papoutsakis, E.T. Antisense RNA strategies for metabolic engineering of Clostridium acetobutylicum. Appl. Environ. Microbiol. 1999, 65, 936–945. [Google Scholar] [PubMed]
  25. Tummala, S.B.; Welker, N.E.; Papoutsakis, E.T. Design of antisense rna constructs for downregulation of the acetone formation pathway of Clostridium acetobutylicum. J. Bacteriol. 2003, 185, 1923–1934. [Google Scholar] [CrossRef] [PubMed]
  26. Gheshlaghi, R.; Scharer, J.M.; Moo-Young, M.; Chou, C.P. Metabolic pathways of Clostridia for producing butanol. Biotechnol. Adv. 2009, 27, 764–781. [Google Scholar] [CrossRef] [PubMed]
  27. Dabrock, B.; Bahl, H.; Gottschalk, G. Parameters affecting solvent production by Clostridium pasteurianum. Appl. Environ. Microbiol. 1992, 58, 1233–1239. [Google Scholar] [PubMed]
  28. Simons, R.; Kleckner, N. Biological regulation by antisense RNA in prokaryotes. Annu. Rev. Genet. 1988, 22, 567–600. [Google Scholar] [CrossRef] [PubMed]
  29. Wagner, E.G.H.; Simons, R.W. Antisense RNA control in bacteria, phages, and plasmids. Annu. Rev. Microbiol. 1994, 48, 713–742. [Google Scholar] [CrossRef] [PubMed]
  30. Tummala, S.B.; Junne, S.G.; Papoutsakis, E.T. Antisense RNA downregulation of coenzyme a transferase combined with alcohol-aldehyde dehydrogenase overexpression leads to predominantly alcohologenic Clostridium acetobutylicum fermentations. J. Bacteriol. 2003, 185, 3644–3653. [Google Scholar] [CrossRef] [PubMed]
  31. Perret, S.; Maamar, H.; Belaich, J.P.; Tardif, C. Use of antisense rna to modify the composition of cellulosomes produced by Clostridium cellulolyticum. Mol. Microbiol. 2004, 51, 599–607. [Google Scholar] [CrossRef] [PubMed]
  32. Nakayama, S.I.; Kosaka, T.; Hirakawa, H.; Matsuura, K.; Yoshino, S.; Furukawa, K. Metabolic engineering for solvent productivity by downregulation of the hydrogenase gene cluster Hupcba in Clostridium saccharoperbutylacetonicum Strain N1-4. Appl. Microbiol. Biotechnol. 2008, 78, 483–493. [Google Scholar] [CrossRef] [PubMed]
  33. Liyanage, H.; Young, M.; Kashket, E.R. Butanol tolerance of Clostridium Beijerinckii NCIMB 8052 associated with down-regulation of GLDA by antisense RNA. J. Mol. Microbiol. Biotechnol. 2000, 2, 87–93. [Google Scholar] [PubMed]
  34. Sillers, R.; A-Hinai, M.A.; Papoutsakis, E.T. Aldehyde-alcohol dehydrogenase and/or thiolase overexpression coupled with coa transferase downregulation lead to higher alcohol titers and selectivity in Clostridium acetobutylicum fermentations. Biotechnol. Bioeng. 2009, 102, 38–49. [Google Scholar] [CrossRef] [PubMed]
  35. Tummala, S.B.; Welker, N.E.; Papoutsakis, E.T. Development and characterization of a gene expression reporter system for Clostridium acetobutylicum ATCC 824. Appl. Environ. Microbiol. 1999, 65, 3793–3799. [Google Scholar] [PubMed]
  36. Heap, J.T.; Pennington, O.J.; Cartman, S.T.; Minton, N.P. A modular system for Clostridium shuttle plasmids. J. Microbiol. Methods 2009, 78, 79–85. [Google Scholar] [CrossRef] [PubMed]
  37. Bruder, M.; Moo-Young, M.; Chung, D.A.; Chou, C.P. Elimination of carbon catabolite repression in Clostridium acetobutylicum—A journey toward simultaneous use of xylose and glucose. Appl. Microbiol. Biotechnol. 2015, 99, 7579–7588. [Google Scholar] [CrossRef] [PubMed]
  38. Sambrook, J.; Fritsch, E.F.; Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed.; Cold Spring Harbor Press: Cold Spring Harbor, NY, USA, 1989. [Google Scholar]
  39. Miller, J.H. Experiments in Molecular Genetics; Gold Spring Harbor Laboratory: Gold Spring Harbor, NY, USA, 1972. [Google Scholar]
  40. Moon, C.; Lee, C.H.; Sang, B.I.; Um, Y. Optimization of medium compositions favoring butanol and 1,3-propanediol production from glycerol by Clostridium pasteurianum. Bioresour. Technol. 2011, 102, 10561–10568. [Google Scholar] [CrossRef] [PubMed]
  41. Graves, M.; Rabinowitz, J. In vivo and in vitro transcription of the Clostridium pasteurianum ferredoxin gene. evidence for “extended” promoter elements in gram-positive organisms. J. Biol. Chem. 1986, 261, 11409–11415. [Google Scholar] [PubMed]
  42. Meng, Y.; Li, J.L. Cloning, expression and characterization of a thiolase gene from Clostridium pasteurianum. Biotechnol. Lett. 2006, 28, 1227–1232. [Google Scholar] [CrossRef] [PubMed]
  43. Guedon, E.; Desvaux, M.; Petitdemange, H. Improvement of cellulolytic properties of Clostridium cellulolyticum by metabolic engineering. Appl. Environ. Microbiol. 2002, 68, 53–58. [Google Scholar] [CrossRef] [PubMed]
  44. Heap, J.T.; Pennington, O.J.; Cartman, S.T.; Carter, G.P.; Minton, N.P. The clostron: A universal gene knock-out system for the genus Clostridium. J. Microbiol. Methods 2007, 70, 452–464. [Google Scholar] [CrossRef] [PubMed]
  45. Rabinowitz, J. Preparation and properties of clostridial ferredoxins. Methods Enzymol. 1971, 24, 431–446. [Google Scholar]
  46. Heyndrickx, M.; Devos, P.; Deley, J. Fermentation characteristics of Clostridium pasteurianum LMG 3285 grown on glucose and mannitol. J. Appl. Bacteriol. 1991, 70, 52–58. [Google Scholar] [CrossRef]
  47. Higashide, W.; Li, Y.C.; Yang, Y.F.; Liao, J.C. Metabolic engineering of Clostridium cellulolyticum for production of isobutanol from cellulose. Appl. Environ. Microbiol. 2011, 77, 2727–2733. [Google Scholar] [CrossRef] [PubMed]
  48. Mermelstein, L.D.; Welker, N.E.; Bennett, G.N.; Papoutsakis, E.T. Expression of cloned homologous fermentative genes in Clostridium acetobutylicum ATCC 824. Bio-Technology 1992, 10, 190–195. [Google Scholar] [CrossRef] [PubMed]
  49. Kim, B.H.; Bellows, P.; Datta, R.; Zeikus, J.G. Control of carbon and electron flow in Clostridium acetobutylicum fermentations—Utilization of carbon monoxide to inhibit hydrogen production and to enhance butanol yields. Appl. Environ. Microbiol. 1984, 48, 764–770. [Google Scholar] [PubMed]

Share and Cite

MDPI and ACS Style

Pyne, M.E.; Moo-Young, M.; Chung, D.A.; Chou, C.P. Antisense-RNA-Mediated Gene Downregulation in Clostridium pasteurianum. Fermentation 2015, 1, 113-126. https://doi.org/10.3390/fermentation1010113

AMA Style

Pyne ME, Moo-Young M, Chung DA, Chou CP. Antisense-RNA-Mediated Gene Downregulation in Clostridium pasteurianum. Fermentation. 2015; 1(1):113-126. https://doi.org/10.3390/fermentation1010113

Chicago/Turabian Style

Pyne, Michael E., Murray Moo-Young, Duane A. Chung, and C. Perry Chou. 2015. "Antisense-RNA-Mediated Gene Downregulation in Clostridium pasteurianum" Fermentation 1, no. 1: 113-126. https://doi.org/10.3390/fermentation1010113

Article Metrics

Back to TopTop